These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8923719)

  • 41. Breed-related plasma disposition of ivermectin following subcutaneous administration in Kilis and Damascus goats.
    Gokbulut C; Bilgili A; Hanedan B; Aksit D; Aksoy AM; Turgut C
    Res Vet Sci; 2009 Dec; 87(3):445-8. PubMed ID: 19410269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil.
    Alvinerie M; Dupuy J; Eeckhoutte C; Sutra JF
    Parasitol Res; 1999 Nov; 85(11):920-2. PubMed ID: 10540953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anthelmintic efficacy, plasma and milk kinetics of eprinomectin following topical and subcutaneous administration to yaks (Bos grumniens).
    Zhang D; Zhang K; Gao J; Liu J; Shahzad M; Han Z; Nabi F; Li K; Li J
    Exp Parasitol; 2015 Jun; 153():17-21. PubMed ID: 25725422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma pharmacokinetics and faecal excretion of ivermectin (Eqvalan paste) and doramectin (Dectomax, 1%) following oral administration in donkeys.
    Gokbulut C; Boyacioglu M; Karademir U
    Res Vet Sci; 2005 Dec; 79(3):233-8. PubMed ID: 16054893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
    Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
    Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma disposition and faecal excretion of eprinomectin following topical and subcutaneous administration in non-lactating dairy cattle.
    Aksit D; Korkut O; Aksoz E; Gokbulut C
    N Z Vet J; 2016 Jul; 64(4):207-11. PubMed ID: 26820168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Milk kinetics of moxidectin and doramectin in goats.
    Carceles CM; Diaz MS; Vicente MS; Sutra JF; Alvinerie M; Escudero E
    Res Vet Sci; 2001 Jun; 70(3):227-31. PubMed ID: 11676618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep.
    Molento MB; Lifschitz A; Sallovitz J; Lanusse C; Prichard R
    Parasitol Res; 2004 Jan; 92(2):121-7. PubMed ID: 14634800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of injectable long-acting ivermectin aqueous suspension following subcutaneous administration in sheep.
    Xu FR; Pan BL; Wang YW; Pan ZD; Dai XX; Liu PH; Wang M
    J Vet Pharmacol Ther; 2007 Oct; 30(5):486-8. PubMed ID: 17803744
    [No Abstract]   [Full Text] [Related]  

  • 50. Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition.
    Ndong TB; Kane Y; Diouf EH; Alvinerie M
    Vet Res Commun; 2007 Aug; 31(6):739-47. PubMed ID: 17260181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dexamethasone treatment interferes with the pharmacokinetics of ivermectin in young cattle.
    Areskog M; von Samson-Himmelstjerna G; Alvinerie M; Sutra JF; Höglund J
    Vet Parasitol; 2012 Dec; 190(3-4):482-8. PubMed ID: 22959189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs.
    Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
    Vet Parasitol; 2006 Feb; 135(3-4):347-54. PubMed ID: 16280198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of moxidectin and doramectin in goats.
    Escudero E; Carceles CM; Diaz MS; Sutra JF; Galtier P; Alvinerie M
    Res Vet Sci; 1999 Oct; 67(2):177-81. PubMed ID: 10502489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of a new ivermectin/praziquantel suspension after intramuscular administration in sheep.
    Tang S; Chen L; Qian M; Hao L; Xiao X
    Vet Parasitol; 2016 May; 221():54-8. PubMed ID: 27084471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans.
    Bassissi MF; Alvinerie M; Lespine A
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Aug; 138(4):437-44. PubMed ID: 15536051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of ivermectin against gastrointestinal nematodes in dromedary camels.
    Boyce W; Kollias G; Courtney CH; Allen J; Chalmers E
    J Am Vet Med Assoc; 1984 Dec; 185(11):1307-8. PubMed ID: 6548996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the dosage of ivermectin in falcons.
    Lierz M
    Vet Rec; 2001 May; 148(19):596-600. PubMed ID: 11386446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction.
    Lifschitz A; Virkel G; Ballent M; Sallovitz J; Lanusse C
    Vet J; 2009 Nov; 182(2):261-8. PubMed ID: 18640064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous periocular Habronema infection in a dromedary camel (Camelus dromedarius).
    Myers DA; Smith CD; Greiner EC; Wiedner E; Abbott J; Marsella R; Nunnery C
    Vet Dermatol; 2010 Oct; 21(5):527-30. PubMed ID: 20500499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Residue depletion of eprinomectin in bovine tissues after subcutaneous administration.
    Jiang H; Hou X; Ding S; Zhao S; He J; Shen J
    J Agric Food Chem; 2005 Nov; 53(23):9288-92. PubMed ID: 16277435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.